175 related articles for article (PubMed ID: 15869323)
1. Ramelteon: TAK 375.
Drugs R D; 2005; 6(3):186-8. PubMed ID: 15869323
[TBL] [Abstract][Full Text] [Related]
2. TAK-375 Takeda.
Cajochen C
Curr Opin Investig Drugs; 2005 Jan; 6(1):114-21. PubMed ID: 15675611
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders.
Miyamoto M
CNS Neurosci Ther; 2009; 15(1):32-51. PubMed ID: 19228178
[TBL] [Abstract][Full Text] [Related]
4. [A novel therapeutic drug: ramelteon].
Miyamoto M
Nihon Rinsho; 2009 Aug; 67(8):1595-600. PubMed ID: 19768947
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.
Kato K; Hirai K; Nishiyama K; Uchikawa O; Fukatsu K; Ohkawa S; Kawamata Y; Hinuma S; Miyamoto M
Neuropharmacology; 2005 Feb; 48(2):301-10. PubMed ID: 15695169
[TBL] [Abstract][Full Text] [Related]
6. Ramelteon: profile of a new sleep-promoting medication.
Owen RT
Drugs Today (Barc); 2006 Apr; 42(4):255-63. PubMed ID: 16703122
[TBL] [Abstract][Full Text] [Related]
7. Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect.
Mini L; Wang-Weigand S; Zhang J
Clin Ther; 2008 Jul; 30(7):1316-23. PubMed ID: 18691991
[TBL] [Abstract][Full Text] [Related]
8. A Case of Unilateral Hypnic Headache: Rapid Response to Ramelteon, a Selective Melatonin MT1/MT2 Receptor Agonist.
Arai M
Headache; 2015; 55(7):1010-1. PubMed ID: 26121162
[No Abstract] [Full Text] [Related]
9. Autoimmune hepatitis in association with ramelteon.
Fourman LT; Robert Meyer B
J Clin Gastroenterol; 2013 Aug; 47(7):651-4. PubMed ID: 23632362
[TBL] [Abstract][Full Text] [Related]
10. Fresh from the pipeline: Ramelteon.
Buysse D; Bate G; Kirkpatrick P
Nat Rev Drug Discov; 2005 Nov; 4(11):881-2. PubMed ID: 16299918
[No Abstract] [Full Text] [Related]
11. A Cluster Headache Responsive to Ramelteon, a Selective Melatonin MT1/MT2 Receptor Agonist.
Imai N
Intern Med; 2016; 55(17):2483-5. PubMed ID: 27580554
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of M-II, the major human metabolite of ramelteon.
Nishiyama K; Nishikawa H; Kato K; Miyamoto M; Tsukamoto T; Hirai K
Pharmacology; 2014; 93(3-4):197-201. PubMed ID: 24923230
[TBL] [Abstract][Full Text] [Related]
13. Effect of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, on motor performance in mice.
Miyamoto M
Neurosci Lett; 2006 Jul; 402(3):201-4. PubMed ID: 16730121
[TBL] [Abstract][Full Text] [Related]
14. Ramelteon, a selective MT1/MT2 receptor agonist, suppresses the proliferation and invasiveness of endometrial cancer cells.
Osanai K; Kobayashi Y; Otsu M; Izawa T; Sakai K; Iwashita M
Hum Cell; 2017 Jul; 30(3):209-215. PubMed ID: 28382516
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: A phase 3, randomized controlled trial.
Mahableshwarkar AR; Calabrese JR; Macek TA; Budur K; Adefuye A; Dong X; Hanson E; Sachs GS
J Affect Disord; 2017 Oct; 221():275-282. PubMed ID: 28662460
[TBL] [Abstract][Full Text] [Related]
16. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
Fisher SP; Davidson K; Kulla A; Sugden D
J Pineal Res; 2008 Sep; 45(2):125-32. PubMed ID: 18298466
[TBL] [Abstract][Full Text] [Related]
17. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
Mini LJ; Wang-Weigand S; Zhang J
Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
[TBL] [Abstract][Full Text] [Related]
18. Ramelteon and improved insomnia in alcohol-dependent patients: a case series.
Brower KJ; Conroy DA; Kurth ME; Anderson BJ; Stein MD
J Clin Sleep Med; 2011 Jun; 7(3):274-5. PubMed ID: 21677897
[TBL] [Abstract][Full Text] [Related]
19. Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.
Wang-Weigand S; Watissée M; Roth T
Sleep Med; 2011 Oct; 12(9):920-3. PubMed ID: 21925941
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.
Nishiyama K; Shintani Y; Hirai K; Yoshikubo S
J Pharmacol Exp Ther; 2009 Sep; 330(3):855-63. PubMed ID: 19556449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
